The Drug-Drug Interactions Ontology - oxyphenbutazone - Classes | NCBO BioPortal

The Drug-Drug Interactions Ontology

Last uploaded: February 11, 2016

Id	http://purl.obolibrary.org/obo/dinto_DB03585 http://purl.obolibrary.org/obo/dinto_DB03585
Preferred Name	oxyphenbutazone
Synonyms	4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione C19H20N2O3
Type	http://www.w3.org/2002/07/owl#Class

prefLabel	oxyphenbutazone
label	oxyphenbutazone
DBSynonym	1-(p-hydroxyphenyl)-2-phenyl-4-butyl-3,5-pyrazolidinedione opb p-oxyphenylbutazone oxiphenbutazone ossifenbutazone [dcit] oxifenbutazona [inn-spanish] 1-p-hydroxyphenyl-2-phenyl-3,5-dioxo-4-n-butylpyrazolidine 4-butyl-2-(4-hydroxyphenyl)-1-phenyl-3,5-dioxopyrazolidine 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione 3,5-pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl hydroxyphenylbutazon oxifenylbutazon usaf ge-14 oxyphenbutazonum [inn-latin] 4-butyl-1-(p-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione 1-phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-butylpyrazolidine oxiphenbutazonum 4-butyl-2-(p-hydroxyphenyl)-1-phenyl-3,5-pyrazolidinedione oxyphenobutazone oxyphenylbutazone p-hydroxyphenylbutazone See more See less
ATCCode	S01BC02 M01AA03 M02AA04
Definition	Oxyphenbutazone was withdrawn from the Canadian market in March 1985 due to concerns regarding bone marrow suppression.
inhibits	http://purl.obolibrary.org/obo/dinto_0520
type	http://www.w3.org/2002/07/owl#Class
InChIKey	InChIKey=HFHZKZSRXITVMK-UHFFFAOYSA-N
Synonym	4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione C19H20N2O3
xref	PharmGKB:PA450750 PubChem Compound:4641 PDB:OPB PubChem Substance:46507285 ChemSpider:4480 Wikipedia:http://en.wikipedia.org/wiki/Oxyphenbutazone See more See less
CASRN	129-20-4
prefixIRI	obo2:dinto_DB03585
related with	http://purl.obolibrary.org/obo/dinto_1311 http://purl.obolibrary.org/obo/dinto_0217
SMILES	CCCCC1C(=O)N(N(C1=O)C1=CC=C(O)C=C1)C1=CC=CC=C1
may interact with	http://purl.obolibrary.org/obo/CHEBI_8107 http://purl.obolibrary.org/obo/CHEBI_4888 http://purl.obolibrary.org/obo/dinto_DB00532 http://purl.obolibrary.org/obo/CHEBI_53766 http://purl.obolibrary.org/obo/CHEBI_133809 http://purl.obolibrary.org/obo/CHEBI_10033 http://purl.obolibrary.org/obo/CHEBI_4513 http://purl.obolibrary.org/obo/dinto_DB01320 http://purl.obolibrary.org/obo/CHEBI_2567 See more See less
InChI	InChI=1S/C19H20N2O3/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15/h4-8,10-13,17,22H,2-3,9H2,1H3
DBBrand	oxyphentamin flopirina oxi-fenibutol flogostop californit butanora isobutil oxazolidin tendearil tanderal rapostan artroflog telidac oxybuton valioil telidal offitril idrobutazina etrozolidina aradinum oxibutol butapirone flogodin crovaril butanova flogitolo oxalid butazonic flogistin infamil floghene neo-farmadol deflogin butilene pirabutina metabolite i butaflogin tandacote visubutina neofen infammil oxazolioin flanaril remazin tandalgesic flegmostam isobutazina oxazolidin-geigy tanderil rumapax frabel cinophen-n portoril poliflogil tandearil flamaril genal piraflogin ipabutona flogal iridil optimal mysite flogoril reunabutal reumox See more See less
subClassOf	http://purl.obolibrary.org/obo/dinto_000055

Subscribe to notes emails

Delete	Subject	Author	Type	Created
No notes to display